Five Antiretroviral Drug Class–Resistant HIV-1 in a Treatment-Naïve Patient Successfully Suppressed with Optimized Antiretroviral Drug Selection

Joseph M. Volpe, Douglas Ward, Laura A. Napolitano, Pham Phung, Jonathan Toma, Owen D. Solberg, Christos J. Petropoulos, Charles Walworth

Journal of the International Association of Providers of AIDS Care (JIAPAC) · 2015 · 19 citations · 11 references

DOIFull text

Open access

Concepts

Abstract

Transmitted HIV-1 exhibiting reduced susceptibility to protease and reverse transcriptase inhibitors is well documented but limited for integrase inhibitors and enfuvirtide. We describe here a case of transmitted 5 drug class-resistance in an antiretroviral (ARV)-naïve patient who was successfully treated based on the optimized selection of an active ARV drug regimen. The value of baseline resistance testing to determine an optimal ARV treatment regimen is highlighted in this case report.

References

11